Readers: Talking Up Off-Label Drugs Won't Impact Practice

(MedPage Today) -- MedPage Today readers said that identifying off-label drug promotion as free speech would not have any bearing on clinical practice. via MedPageToday.com - medical news plus CME for physicians Read More Here..